GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Cyanotech Corp (OTCPK:CYAN) » Definitions » GF Value
中文

Cyanotech (Cyanotech) GF Value

: $1.57 (As of Today)
View and export this data going back to 1993. Start your Free Trial

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-04-23), Cyanotech's share price is $0.3005. Cyanotech's GF Value is $1.57. Therefore, Cyanotech's Price-to-GF-Value for today is 0.19.

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Cyanotech is Possible Value Trap, Think Twice.


Cyanotech  (OTCPK:CYAN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Cyanotech's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.3005/1.57
=0.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyanotech GF Value Related Terms

Thank you for viewing the detailed overview of Cyanotech's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyanotech (Cyanotech) Business Description

Traded in Other Exchanges
N/A
Address
73-4460 Queen Kaahumanu Highway, Suite 102, Kailua-Kona, HI, USA, 96740
Cyanotech Corp is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The company's products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. BioAstin Hawaiian Astaxanthin is a dietary antioxidant shown to support and maintain the body's natural inflammatory response, enhance skin, and support eye and joint health. It derives maximum revenue from the Packaged product and geographically from the United States.
Executives
Kakuk Collette Nicole officer: Chief Strategic Comml Officer 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Michael A / Davis director, 10 percent owner 1621 JUANITA LANE, TIBURON CA 94920
Angela May Mcelwee director 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Charles Jason Hartmann officer: VP, Sales & Marketing 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA-KONA HI 96740
Glenn Jensen officer: VP-Operations 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA-KONA HI 96740
Jennifer M. Johansen officer: VP of Quality 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Walter Bennett Menzel director 45 MOUNT TIBURON ROAD, TIBURON CA 94920
Felicia I Ladin officer: CFO, VP Fin & Admin, Treasurer 26 CORPORATE CIRCLE, ALBANY NY 12203
Matthew Keith Custer officer: Vice President, Gen Mgr 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA HI 96740
Amy Beth Nordin officer: VP, HR, Secretary 73-4460 QUEEN KAAHUMANU HWY. SUITE 102, KAILUA-KONA HI 96740
Brian Brett Orlopp officer: CFO, VP, Treasurer, Secretary 73-4460 QUEEN KAAHUMANU HWY #102, KAILUA KONA CA 96740
Gerald J Watts officer: COO 2530 RED HILL AVE, SANTA ANA CA 92705
Mawae Morton officer: President 7473 MAKA'A STREET, HONOLULU HI 96825
Nancy E Katz director CALYPTE BIOMEDICAL CORP, 1265 HARBOR BAY PKWY, ALAHEDA CA 94502
David M Mulder director 21771 CALATRAVA, MISSION VIEJO CA 92692